Analysis of the Impact of Patent Ductus Arteriosus on Brain Function in Preterm Neonates: Multimodal Approach Integrating EEG-NIRS, Ultrasound and Clinical Data (NNP-MULTIMODAL)
Ductus Arteriosus, Patent
About this trial
This is an interventional basic science trial for Ductus Arteriosus, Patent focused on measuring preterm neonates, EEG-NIRS
Eligibility Criteria
Inclusion Criteria:
Group of children :
- meeting the age criteria
- having a ductus arteriosus persistence.
Group of children :
- meeting the age criteria
- with persistent ductus arteriosus in the ultrasound examination
- for which a cardiac or respiratory treatment has already been put in place.
normal group of children :
- meeting the age criteria
- without ductus arteriosus persistence ultrasound or detectable neurological disorders after clinical, neurophysiological and radiological (ETF , Scanner, MRI).
Exclusion Criteria:
-
Sites / Locations
- CHU Amiens
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
Experimental
patent ductus arteriosus
without patent ductus arteriosus
patent ductus arteriosus + cardiac or respiratory therapy
ultrasounds Transfontanellaires near-infrared spectroscopy (TFU-NIRS) near-infrared spectroscopy (NIRS) electroencephalogram (EEG)
ultrasounds Transfontanellaires near-infrared spectroscopy (TFU-NIRS) near-infrared spectroscopy (NIRS) electroencephalogram (EEG)
ultrasounds Transfontanellaires near-infrared spectroscopy (TFU-NIRS) near-infrared spectroscopy (NIRS) electroencephalogram (EEG)